In its first test in people, a new vaccine shows signs of fighting prostate cancer in men who have the disease. The treatment enlists a person’s own immune cells to attack prostate tissue, including cancerous tissue. Despite assaulting some healthy cells, the vaccine appears safe and potentially effective in people, say scientists at Duke University Medical Center in Durham, N.C.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.